People · Operator

Susan A. Langer

Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology

1
Companies
1
Filings
$23.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NextRNA Therapeutics, Inc.BiotechnologySeries B$23.4M$480.8M2022
Operator network

Susan A. Langer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Marc A. Cohen · 5 companies · 1 sharedMarc A. CohenCarl A. Novina · 3 companies · 1 sharedCarl A. NovinaElena A. Prokupets · 3 companies · 1 sharedElena A. ProkupetsJulia A. Novina · 3 companies · 1 sharedJulia A. NovinaArthur A. Becker · 2 companies · 1 sharedArthur A. BeckerBarry A. Polisky · 2 companies · 1 sharedBarry A. PoliskyDominique A. Verhelle · 2 companies · 1 sharedDominique A. Verh…Drew A. Dennison · 2 companies · 1 sharedDrew A. DennisonKenneth A. Anderson · 2 companies · 1 sharedKenneth A. Anders…Malcolm A. Salter · 2 companies · 1 sharedMalcolm A. SalterAlain A. Cohen · 1 companies · 1 sharedAlain A. CohenAndrea A. Armstrong · 1 companies · 1 sharedAndrea A. Armstro…Christine A. Henderson · 1 companies · 1 sharedChristine A. Hend…Fred A. Mermelstein · 1 companies · 1 sharedFred A. Mermelste…NextRNA Therapeutics, Inc. · $23.4M raisedNextRNA Therapeutics,…Susan A. LangerSL
Susan A. Langer Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Susan A. Langer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Marc A. Cohen15
Julia A. Novina13
Elena A. Prokupets13
Carl A. Novina13
Barry A. Polisky12
Malcolm A. Salter12
Dominique A. Verhelle12
Drew A. Dennison12
Arthur A. Becker12
Kenneth A. Anderson12
Christine A. Henderson11
Fred A. Mermelstein11
Alain A. Cohen11
Andrea A. Armstrong11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.